+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

HD4, A 180-KD bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome



HD4, A 180-KD bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome



Cell Structure & Function 17(6): 476




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031633804

Download citation: RISBibTeXText


Related references

HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. Journal of Biochemistry 113(4): 493-501, 1993

Human autoantibodies against the 230-kD bullous pemphigoid antigen bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen bind along the plasma membrane of the hemidesmosome in normal human and swine skin. Journal of Clinical Investigation 91(4): 1608-1615, 1993

Pemphigoid vegetans represents a bullous pemphigoid variant. Patient's IgG autoantibodies identify the major bullous pemphigoid antigen. Journal of the American Academy of Dermatology 28(2 Pt 2): 331-335, 1993

Identification of polarization and hemidesmosome targeting sequences in the bullous pemphigoid 180kD antigen. Journal of Investigative Dermatology 104(4): 583, 1995

A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. Journal of Investigative Dermatology 84(1): 47-53, 1985

The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. Journal of Investigative Dermatology 99(2): 174-179, 1992

Rat mouse hybridomas producing monoclonal antibodies reactive with a basal cell hemidesmosome antigen similarly to human bullous pemphigoid autoantibodies. Clinical Researchpart 1: 297a, 1985

IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. Journal of Immunology 157(8): 3642-3647, 1996

Hemidesmosome formation is initiated by the b4 integrin subunit, requires complex formation of b4 and HD1/plectin, and involves a direct interaction between b4 and the bullous pemphigoid antigen 180. The Journal of Cell Biology 142(1): 1-84, 1998

Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid. European Journal of Dermatology 9(1): 39-42, 1999

Evidence that the 180-kD bullous pemphigoid antigen is a transmembrane collagen, type XVII, in a triple-helical conformation and in type II transmembrane topography. Journal of Investigative Dermatology 106(4): 860, 1996

Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. British Journal of Dermatology 154(1): 90-98, 2006

The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16s domain of the 180-kDa bullous pemphigoid antigen. Archives of Dermatological Research 288(9): 507-509, 1996

In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigen. Journal of Investigative Dermatology 105(6): 824-830, 1995

IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA. Journal of Immunology 145(11): 3728-3733, 1990